Forget calorie counting: Diet low in specific amino acids may be the key to weight loss

December 20, 2017

A worldwide epidemic of diabetes and obesity has led many individuals to try to lose weight by dieting - but reduced-calorie diets are notoriously difficult to maintain. New research published in the Journal of Physiology indicates that lowering consumption of specific building blocks of proteins (amino acids) may combat the metabolic problems that occur in diabetes and obesity.

In a mouse study, researchers at the University of Wisconsin-Madison found that lowering the consumption of specific types of amino acids called branched-chain amino acids (BCAAs) improved metabolic health, even when overall calories were not reduced.

The study found that feeding obese, pre-diabetic mice a specialized diet low in the amino acids leucine, isoleucine and valine promoted leanness and improved the regulation of blood sugar. The researchers examined their weight, body composition, glucose metabolism and energy expenditure.

Importantly, mice in this study were free to eat as much of the low-BCAA food as they wanted, and thus did not experience overall calorie reduction. Despite continuing to eat an unhealthy high-fat and high-sugar diet, mice on the low-BCAA diet still experienced an improvement in metabolic health.

If these results can be translated to humans, it is possible that such diets, or drugs that mimic the effect of a low-BCAA diet, would be easier for people to follow and more effective than traditional calorie-counting diets.

The research team hopes that a low-BCAA dietary approach could be an effective way to treat or prevent metabolic syndrome, which is a group of conditions including high blood pressure, high blood sugar, abnormal cholesterol levels, and excess abdominal fat that collectively increase the risk of diabetes, heart disease, and stroke.

Researchers will next investigate whether reducing dietary BCAAs can improve the metabolic health of humans, and how the specific amino acid composition of dietary protein regulates metabolic health. This could help explain the wide variation seen between individuals in response to different weight-loss diets.

Dr. Dudley Lamming, one of the lead investigators on the project, commented on the findings:

'We've identified an unanticipated role for dietary BCAAs in the regulation of energy balance, and we show that a diet with low levels of BCAAs promotes leanness and good control of blood sugar. Our results also suggest that the specific amino acid composition of dietary protein - not just how much protein we eat - regulates metabolic health.'
-end-


The Physiological Society

Related Diabetes Articles from Brightsurf:

New diabetes medication reduced heart event risk in those with diabetes and kidney disease
Sotagliflozin - a type of medication known as an SGLT2 inhibitor primarily prescribed for Type 2 diabetes - reduces the risk of adverse cardiovascular events for patients with diabetes and kidney disease.

Diabetes drug boosts survival in patients with type 2 diabetes and COVID-19 pneumonia
Sitagliptin, a drug to lower blood sugar in type 2 diabetes, also improves survival in diabetic patients hospitalized with COVID-19, suggests a multicenter observational study in Italy.

Making sense of diabetes
Throughout her 38-year nursing career, Laurel Despins has progressed from a bedside nurse to a clinical nurse specialist and has worked in medical, surgical and cardiac intensive care units.

Helping teens with type 1 diabetes improve diabetes control with MyDiaText
Adolescence is a difficult period of development, made more complex for those with Type 1 diabetes mellitus (T1DM).

Diabetes-in-a-dish model uncovers new insights into the cause of type 2 diabetes
Researchers have developed a novel 'disease-in-a-dish' model to study the basic molecular factors that lead to the development of type 2 diabetes, uncovering the potential existence of major signaling defects both inside and outside of the classical insulin signaling cascade, and providing new perspectives on the mechanisms behind insulin resistance in type 2 diabetes and possibly opportunities for the development of novel therapeutics for the disease.

Tele-diabetes to manage new-onset diabetes during COVID-19 pandemic
Two new case studies highlight the use of tele-diabetes to manage new-onset type 1 diabetes in an adult and an infant during the COVID-19 pandemic.

Genetic profile may predict type 2 diabetes risk among women with gestational diabetes
Women who go on to develop type 2 diabetes after having gestational, or pregnancy-related, diabetes are more likely to have particular genetic profiles, suggests an analysis by researchers at the National Institutes of Health and other institutions.

Maternal gestational diabetes linked to diabetes in children
Children and youth of mothers who had gestational diabetes during pregnancy are at increased risk of diabetes themselves, according to new research published in CMAJ (Canadian Medical Association Journal).

Two diabetes medications don't slow progression of type 2 diabetes in youth
In youth with impaired glucose tolerance or recent-onset type 2 diabetes, neither initial treatment with long-acting insulin followed by the drug metformin, nor metformin alone preserved the body's ability to make insulin, according to results published online June 25 in Diabetes Care.

People with diabetes visit the dentist less frequently despite link between diabetes, oral health
Adults with diabetes are less likely to visit the dentist than people with prediabetes or without diabetes, finds a new study led by researchers at NYU Rory Meyers College of Nursing and East Carolina University's Brody School of Medicine.

Read More: Diabetes News and Diabetes Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.